Bill Texts: LA HB920 | 2026 | Regular Session

Bill Title: Requires drug manufacturers to limit pricing of GLP-1 medications for health insurance plans (OR INCREASE GF EX See Note)

Sponsorship: Partisan Bill (Democrat 1)

Status: (Introduced - Dead) 2026-03-09 - Read by title, under the rules, referred to the Committee on Insurance. [HB920 Detail]

Bill Drafts

RevisionDateFormatSourceView
IntroducedNot AvailPDFLinkView

Amendments

AmendmentDateDispositionFormatSourceView
House Committee Amendment #3925 INS DraftNot AvailProposedPDFLinkView
House Committee Amendment #3930 INS DraftNot AvailProposedPDFLinkView

Supplemental Documents

TitleDescriptionDateFormatSourceView
AnalysisDigest of HB920 OriginalNot AvailPDFLinkView
Fiscal NoteFiscal Note - HB920 OriginalNot AvailPDFLinkView

feedback